COPD急性加重管理:ERS/ATS指南
该指南由欧洲呼吸学会(ERS)与美国胸科学会(ATS)联合制定,针对慢性阻塞性肺疾病(COPD)急性加重的治疗提出临床推荐。工作组基于系统评价与荟萃分析,采用GRADE方法评估证据,经多学科专家组讨论后形成推荐:强烈推荐急性或慢性急性呼吸衰竭患者使用无创机械通气;对口服激素、抗生素、家庭管理及出院3周内启动肺康复给出条件性推荐;条件性不推荐住院期间启动肺康复。
要点
- 急性或慢性急性呼吸衰竭的COPD急性加重患者,强烈推荐无创机械通气。
- 门诊患者可口服激素,住院患者优先口服而非静脉激素,均为条件性推荐。
- 条件性推荐抗生素治疗、家庭管理及出院3周内启动肺康复;不推荐住院期间启动肺康复。
核心结论
- 工作组就COPD急性加重的激素治疗、抗生素治疗、无创机械通气、家庭管理和早期肺康复提出推荐,并指出应随新证据更新。
研究设计与样本
- 由ERS/ATS多学科COPD专家工作组制定指南,基于系统评价和荟萃分析汇总证据,采用GRADE方法评估并形成推荐。
主要发现
- 对急性或慢性急性呼吸衰竭患者,强烈推荐无创机械通气。
- 对门诊患者口服激素、住院患者口服而非静脉激素、抗生素治疗、家庭管理及出院3周内启动肺康复,给出条件性推荐。
- 对住院期间启动肺康复,给出条件性不推荐。
关键数值与推荐
- 强烈推荐:急性或慢性急性呼吸衰竭患者使用无创机械通气。
- 条件性推荐:门诊患者口服激素;住院患者口服而非静脉激素;抗生素治疗;家庭管理;出院3周内启动肺康复。
- 条件性不推荐:住院期间启动肺康复。
临床怎么用
- COPD急性加重伴急性或慢性急性呼吸衰竭时,应使用无创机械通气。
- 门诊患者可考虑口服激素;住院患者优先选择口服而非静脉激素。
- 可考虑抗生素治疗、家庭管理及出院3周内启动肺康复,但不应在住院期间启动肺康复。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This document provides clinical recommendations for treatment of chronic obstructive pulmonary disease (COPD) exacerbations.Comprehensive evidence syntheses, including meta-analyses, were performed to summarise all available evidence relevant to the Task Force's questions. The evidence was appraised using the Grading of Recommendations, Assessment, Development and Evaluation approach and the results were summarised in evidence profiles. The evidence syntheses were discussed and recommendations formulated by a multidisciplinary Task Force of COPD experts.After considering the balance of desirable and undesirable consequences, quality of evidence, feasibility, and acceptability of various interventions, the Task Force made: 1) a strong recommendation for noninvasive mechanical ventilation of patients with acute or acute-on-chronic respiratory failure; 2) conditional recommendations for oral corticosteroids in outpatients, oral rather than intravenous corticosteroids in hospitalised patients, antibiotic therapy, home-based management, and the initiation of pulmonary rehabilitation within 3 weeks after hospital discharge; and 3) a conditional recommendation against the initiation of pulmonary rehabilitation during hospitalisation.The Task Force provided recommendations related to corticosteroid therapy, antibiotic therapy, noninvasive mechanical ventilation, home-based management, and early pulmonary rehabilitation in patients having a COPD exacerbation. These recommendations should be reconsidered as new evidence becomes available.
引用
- Wedzicha JA, Miravitlles M, Hurst JR, et al. Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline. Eur Respir J. 2017. PMID: 28298398. doi:10.1183/13993003.00791-2016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。